Ilika plc

("Ilika", the "Group". or the "Company")

Award of Share Options, Exercise of Options and Total Voting Rights

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that, on 24 February 2025, it granted options to certain Executive Directors and employees under the Long Term Incentive Plan approved by shareholders in 2018 ("LTIP") and the EMI employee option scheme.

LTIP

Ilika awarded options under the LTIP over 1,208,800 ordinary shares of 1p each in the Company ("Ordinary Shares") to two Executive Directors and over a further 10,000 Ordinary Shares to certain employees, including persons discharging managerial responsibilities ("PDMRs"). Each award has an exercise price equal to the nominal value of an Ordinary Share (1p) and vests on the achievement of certain performance targets over a three-year period. 

Details of grants issued under the LTIP by each Executive Director are set out in the table below, together with the total number of Ordinary Shares each Executive Director holds under option and is interested in.

EMI option scheme

Ilika granted options over 890,832 Ordinary Shares to employees under the Company's EMI option scheme.  EMI options have an exercise price of 34p per Ordinary Share and vest on the achievement of certain performance targets over a three-year period. 

The awards are intended to align the incentives of the Executive Directors and other senior employees with the Company's performance and outcomes for shareholders over the long term, and to provide effective and attractive levels of reward, based on delivering strong financial and operational performance in a fair and proportionate manner.

In total, options over 2,109,632 Ordinary Shares have been awarded under the LTIP and the EMI option scheme, representing 1.26% of the current issued share capital.

Exercise of Options and Total Voting Rights

Ilika also announces that, following the vesting and exercise of options under the Company's share option schemes, it has issued 805,975 new Ordinary Shares at an exercise price of 1p ("New Ordinary Shares"). Accordingly, the Company has applied to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00am on 4 March 2025.

The New Ordinary Shares represent 0.48 per cent of the Company's current issued share capital.

Total Voting Rights

Following Admission, the Company's issued share capital will comprise 168,109,066 Ordinary Shares and that number may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.  The Company does not hold any shares in treasury. 

For more information contact:

About Ilika plc - https://www.ilika.com

Ilika is a global expert in the development of solid state battery technology for electric vehicles, medical devices and consumer appliances. The Company's pioneering next-generation technologies aim to provide scalable, affordable alternatives to conventional batteries, to industries which need to incorporate a smaller, lighter, and safer power source in their products.

The Company has two product lines. Its Stereax batteries are designed for powering miniature medical implants, industrial wireless sensors and Internet of Things (IoT) applications and the Goliath large format batteries designed for EV cars and cordless appliances.

Through its licensing business model, Ilika supplies its IP portfolio to both OEMs and manufacturing partners in exchange for a license fee and future royalties